%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Stefanie Ginster, Maureen Bardet, Adeline Unterreiner, Claire Malinverni, Florian Renner, Stephen Lam, Felix Freuler, Bertran Gerrits, Johannes Voshol, Thomas Calzascia, Catherine H. Régnier, Martin Renatus, Rainer Nikolay, Laura Israël, Frédéric Bornancin
Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 11 0 R/Contents 12 0 R/TrimBox[0 0 612 792]>>
endobj
11 0 obj
[13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref001)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref002)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref003)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref004)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref007)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref009)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref010)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref009)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref011)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref012)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref014)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref015)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref016)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref017)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref010)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref018)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref019)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref020)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.g001)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.g001)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref021)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpone.0169026.ref022)>>
endobj
12 0 obj
[38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R]
endobj
38 0 obj
<>stream
q
0.83 0.64 0.02 0 k
302.8535 674.9858 m
307.6157 674.9858 l
h
f*
448.1575 662.0031 m
452.9197 662.0031 l
h
f*
457.3984 662.0031 m
462.1606 662.0031 l
h
f*
428.0315 596.9764 m
432.7937 596.9764 l
h
f*
311.9244 558.0283 m
316.6866 558.0283 l
h
f*
552.8126 532.0063 m
557.5748 532.0063 l
h
f*
290.4378 505.9843 m
295.2 505.9843 l
h
f*
299.6787 505.9843 m
304.3843 505.9843 l
h
f*
498.3874 493.0016 m
503.1496 493.0016 l
h
f*
507.6283 493.0016 m
517.1528 493.0016 l
h
f*
221.9528 466.9795 m
226.715 466.9795 l
h
f*
265.8898 466.9795 m
275.3575 466.9795 l
h
f*
336.0756 466.9795 m
345.6 466.9795 l
h
f*
350.7591 466.9795 m
360.2835 466.9795 l
h
f*
473.6126 466.9795 m
483.137 466.9795 l
h
f*
305.4047 453.9969 m
314.9291 453.9969 l
h
f*
379.1055 453.9969 m
388.6299 453.9969 l
h
f*
349.3984 441.0142 m
358.9228 441.0142 l
h
f*
367.4268 389.0268 m
376.9512 389.0268 l
h
f*
529.2283 375.9874 m
538.7528 375.9874 l
h
f*
536.0882 336.9827 m
545.6126 336.9827 l
h
f*
243.4394 297.978 m
262.9984 297.978 l
h
f*
457.6819 272.0126 m
477.2409 272.0126 l
h
f*
455.3575 94.9039 m
464.8819 94.9039 l
h
f*
261.2409 81.9213 m
270.7654 81.9213 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Mucosa)Tj
3.3618 0 Td
(associated)Tj
4.2576 0 Td
(lymphoid)Tj
4.0876 0 Td
(tissue)Tj
2.4604 0 Td
(lymphoma)Tj
4.5468 0 Td
(translocation)Tj
5.4651 0 Td
(protein)Tj
3.1521 0 Td
(1\(MALT1\))Tj
4.5751 0 Td
(also)Tj
1.7688 0 Td
(known)Tj
3.0047 0 Td
(as)Tj
-36.68 -1.3039 Td
(paracaspase)Tj
4.9265 0 Td
(1)Tj
0.6974 0 Td
(\(PCASP1\))Tj
4.3199 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(])Tj
1.372 0 Td
(plays)Tj
2.2337 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
4.2859 0 Td
(role)Tj
1.7631 0 Td
(during)Tj
2.9311 0 Td
(immune)Tj
3.6226 0 Td
(responses)Tj
4.0989 0 Td
(triggered)Tj
3.8324 0 Td
(by)Tj
-35.2854 -1.2982 Td
(antigen)Tj
3.2031 0 Td
(receptors)Tj
3.9174 0 Td
(and)Tj
1.7292 0 Td
(C-type)Tj
2.931 0 Td
(lectin)Tj
2.4264 0 Td
(receptors)Tj
3.9175 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(Dectins)Tj
3.2768 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(3)Tj
0 g
(].)Tj
1.2585 0 Td
(After)Tj
2.2848 0 Td
(engagement)Tj
5.0739 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(B)Tj
-36.8388 -1.2983 Td
(cell)Tj
1.559 0 Td
(receptor)Tj
3.5546 0 Td
(\(BCR\),)Tj
2.9934 0 Td
(the)Tj
1.4683 0 Td
(T)Tj
0.8277 0 Td
(cell)Tj
1.5591 0 Td
(receptor)Tj
3.5603 0 Td
(\(TCR\))Tj
2.7949 0 Td
(or)Tj
1.0999 0 Td
(Dectin-1/2,)Tj
4.7735 0 Td
(phosphorylation)Tj
6.8087 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(relevant)Tj
-33.4826 -1.3039 Td
(CARD)Tj
2.9253 0 Td
(protein)Tj
3.1521 0 Td
(\(CARD11,)Tj
4.439 0 Td
(also)Tj
1.7688 0 Td
(known)Tj
3.0047 0 Td
(as)Tj
1.0148 0 Td
(CARMA1,)Tj
4.4674 0 Td
(in)Tj
1.0375 0 Td
(lymphocytes;)Tj
5.4765 0 Td
(CARD9)Tj
3.4015 0 Td
(in)Tj
1.0375 0 Td
(myeloid)Tj
3.4639 0 Td
(cells\))Tj
-35.189 -1.2983 Td
(triggers)Tj
3.2428 0 Td
(a)Tj
0.6519 0 Td
(conformational)Tj
6.4233 0 Td
(change.)Tj
3.2655 0 Td
(This)Tj
1.9842 0 Td
(enables)Tj
3.1635 0 Td
(the)Tj
1.474 0 Td
(specific)Tj
3.1918 0 Td
(CARD)Tj
2.9253 0 Td
(protein)Tj
3.1521 0 Td
(to)Tj
1.0261 0 Td
(act)Tj
1.372 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(nucle-)Tj
-33.5449 -1.2982 Td
(ation)Tj
2.2733 0 Td
(center)Tj
2.7099 0 Td
(for)Tj
1.3833 0 Td
(building,)Tj
3.8041 0 Td
(together)Tj
3.5376 0 Td
(with)Tj
1.9956 0 Td
(pre-assembled)Tj
5.9867 0 Td
(BCL10-MALT1)Tj
6.5027 0 Td
(complexes,)Tj
4.6317 0 Td
(a)Tj
0.6577 0 Td
(multi-)Tj
-33.4826 -1.304 Td
(meric)Tj
2.5228 0 Td
(filament-like)Tj
5.3291 0 Td
(activated)Tj
3.7814 0 Td
(CBM)Tj
3.1407 0 Td
(complex)Tj
3.6227 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(cell)Tj
1.559 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5988 0 Td
(The)Tj
1.7858 0 Td
(CBM)Tj
2.3527 0 Td
(complex)Tj
3.6227 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(essential)Tj
-33.8738 -1.2982 Td
(scaffolding)Tj
4.575 0 Td
(platform)Tj
3.7021 0 Td
(that)Tj
1.7801 0 Td
(connects)Tj
3.7531 0 Td
(via)Tj
1.3719 0 Td
(TRAF6)Tj
3.1408 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(inhibitor)Tj
3.7814 0 Td
(of)Tj
1.0147 0 Td
(kappa)Tj
2.6192 0 Td
(B)Tj
0.7994 0 Td
(kinase)Tj
2.7553 0 Td
(\(IKK\))Tj
2.5851 0 Td
(com-)Tj
-34.3726 -1.2983 Td
(plex,)Tj
2.0976 0 Td
(leading)Tj
3.1294 0 Td
(to)Tj
1.0261 0 Td
(canonical)Tj
4.0536 0 Td
(NF-)Tj
/F12 1 Tf
()Tj
/F8 1 Tf
(B)Tj
2.9536 0 Td
(activation.)Tj
4.3767 0 Td
(The)Tj
1.7802 0 Td
(CBM)Tj
2.3584 0 Td
(complex)Tj
3.6226 0 Td
(also)Tj
1.7688 0 Td
(regulates)Tj
3.7701 0 Td
(other)Tj
2.347 0 Td
(pathways)Tj
-33.2841 -1.2983 Td
(like)Tj
1.6497 0 Td
(JNK)Tj
1.9616 0 Td
(and)Tj
1.7291 0 Td
(p38)Tj
1.6894 0 Td
(signaling)Tj
3.8211 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.6044 0 Td
(The)Tj
1.7802 0 Td
(critical)Tj
2.9536 0 Td
(function)Tj
3.6284 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(CBM)Tj
2.3584 0 Td
(was)Tj
1.6951 0 Td
(exemplified)Tj
4.8926 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(number)Tj
-33.9361 -1.3039 Td
(of)Tj
1.0147 0 Td
(studies)Tj
2.9877 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4684 0 Td
(mouse)Tj
2.863 0 Td
(where)Tj
2.6475 0 Td
(knocking)Tj
3.9742 0 Td
(out)Tj
1.5533 0 Td
(any)Tj
1.6554 0 Td
(of)Tj
1.0148 0 Td
(its)Tj
1.1452 0 Td
(components)Tj
5.1761 0 Td
(led)Tj
1.4173 0 Td
(to)Tj
1.0261 0 Td
(blockade)Tj
3.7871 0 Td
(of)Tj
1.0148 0 Td
(NF-)Tj
/F12 1 Tf
()Tj
/F8 1 Tf
(B)Tj
-33.7774 -1.2982 Td
(activation)Tj
4.1498 0 Td
(following)Tj
3.9799 0 Td
(immune)Tj
3.6283 0 Td
(receptor)Tj
3.5546 0 Td
(stimulation,)Tj
5.023 0 Td
(resulting)Tj
3.7247 0 Td
(in)Tj
1.0374 0 Td
(poor)Tj
2.1203 0 Td
(immune)Tj
3.6284 0 Td
(responses)Tj
4.0932 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
-34.9396 -1.2983 Td
(Human)Tj
3.3165 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(CBM)Tj
2.3584 0 Td
(deficiencies)Tj
4.8642 0 Td
(were)Tj
2.1203 0 Td
(also)Tj
1.7688 0 Td
(identified)Tj
4.0592 0 Td
(all)Tj
1.1452 0 Td
(of)Tj
1.0148 0 Td
(whom)Tj
2.7609 0 Td
(displayed)Tj
3.9798 0 Td
(combined)Tj
-32.7512 -1.3039 Td
(immuno-deficiencies)Tj
8.7023 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(8)Tj
0 g
(].)Tj
1.2586 0 Td
(Beyond)Tj
3.2598 0 Td
(this)Tj
1.6781 0 Td
(essential)Tj
3.583 0 Td
(scaffolding)Tj
4.5751 0 Td
(role,)Tj
1.9899 0 Td
(MALT1)Tj
3.4242 0 Td
(was)Tj
1.7008 0 Td
(shown)Tj
2.8459 0 Td
(to)Tj
1.0262 0 Td
(have)Tj
-35.3081 -1.2983 Td
(arginine)Tj
3.5432 0 Td
(directed)Tj
3.481 0 Td
(proteolytic)Tj
4.5354 0 Td
(activity)Tj
3.1181 0 Td
(triggered)Tj
3.8324 0 Td
(by)Tj
1.1848 0 Td
(CBM)Tj
2.3528 0 Td
(complex)Tj
3.6226 0 Td
(assembly)Tj
3.8268 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(10)Tj
0 g
(].)Tj
1.7348 0 Td
(Several)Tj
-32.4961 -1.2982 Td
(MALT1)Tj
3.4185 0 Td
(proteolytic)Tj
4.5354 0 Td
(substrates)Tj
4.1612 0 Td
(have)Tj
2.0637 0 Td
(been)Tj
2.1203 0 Td
(identified,)Tj
4.2859 0 Td
(including)Tj
4.0422 0 Td
(ubiquitination)Tj
5.9924 0 Td
(regulators)Tj
4.2236 0 Td
(like)Tj
-34.8432 -1.304 Td
(A20)Tj
1.8538 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(],)Tj
1.5987 0 Td
(CYLD)Tj
2.795 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(])Tj
1.8481 0 Td
(and)Tj
1.7292 0 Td
(HOIL-1)Tj
3.4412 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(],)Tj
3.5433 0 Td
(the)Tj
1.4683 0 Td
(NF-)Tj
/F12 1 Tf
()Tj
/F8 1 Tf
(B)Tj
2.9537 0 Td
(subunit)Tj
3.2598 0 Td
(RELB)Tj
2.5285 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(])Tj
1.8482 0 Td
(or)Tj
1.0998 0 Td
(mRNA)Tj
3.0841 0 Td
(turnover)Tj
-33.0517 -1.2982 Td
(regulators)Tj
4.2235 0 Td
(like)Tj
1.6555 0 Td
(Regnase-1)Tj
4.3199 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
2.0807 0 Td
(and)Tj
1.7291 0 Td
(Roquins)Tj
3.5603 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.0749 0 Td
(In)Tj
1.1112 0 Td
(addition,)Tj
3.8211 0 Td
(the)Tj
1.4683 0 Td
(CBM)Tj
2.3584 0 Td
(component)Tj
4.8132 0 Td
(BCL10)Tj
-33.2161 -1.2983 Td
(was)Tj
1.6951 0 Td
(shown)Tj
2.8516 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(a)Tj
0.652 0 Td
(MALT1)Tj
3.4242 0 Td
(substrate)Tj
3.7984 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.0806 0 Td
(While)Tj
2.6475 0 Td
(the)Tj
1.4684 0 Td
(understanding)Tj
6.0718 0 Td
(of)Tj
1.0147 0 Td
(MALT1)Tj
3.4186 0 Td
(biology)Tj
3.1748 0 Td
(is)Tj
-34.4747 -1.2983 Td
(expanding)Tj
4.4163 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(identification)Tj
5.5899 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(substrates,)Tj
4.388 0 Td
(the)Tj
1.4684 0 Td
(mechanisms)Tj
5.2043 0 Td
(of)Tj
1.0148 0 Td
(MALT1)Tj
3.4243 0 Td
(protease)Tj
3.5546 0 Td
(acti-)Tj
-35.4158 -1.3039 Td
(vation)Tj
2.7269 0 Td
(have)Tj
2.0636 0 Td
(not)Tj
1.5704 0 Td
(been)Tj
2.1259 0 Td
(fully)Tj
1.9786 0 Td
(elucidated.)Tj
4.5467 0 Td
(In)Tj
1.1112 0 Td
(addition)Tj
3.5943 0 Td
(to)Tj
1.0262 0 Td
(cleaving)Tj
3.4809 0 Td
(substrates,)Tj
4.388 0 Td
(MALT1)Tj
3.4242 0 Td
(was)Tj
1.7008 0 Td
(recently)Tj
-33.7377 -1.2982 Td
(reported)Tj
3.6566 0 Td
(to)Tj
1.0262 0 Td
(undergo)Tj
3.5943 0 Td
(N-terminal)Tj
4.7111 0 Td
(auto-cleavage)Tj
5.6466 0 Td
(after)Tj
2.0353 0 Td
(R149,)Tj
2.4888 0 Td
(a)Tj
0.6576 0 Td
(mechanism)Tj
4.8415 0 Td
(shown)Tj
2.8517 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(impor-)Tj
-33.6867 -1.2983 Td
(tant)Tj
1.7971 0 Td
(for)Tj
1.389 0 Td
(NF-)Tj
/F12 1 Tf
()Tj
/F8 1 Tf
(B)Tj
2.948 0 Td
(transcriptional)Tj
6.1171 0 Td
(activation)Tj
4.1499 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0806 0 Td
(Mono-ubiquitination)Tj
8.793 0 Td
(at)Tj
0.9525 0 Td
(K644)Tj
2.3244 0 Td
(was)Tj
1.6951 0 Td
(also)Tj
1.7688 0 Td
(reported)Tj
-34.0155 -1.3039 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1508 0 Td
(a)Tj
0.652 0 Td
(key)Tj
1.5931 0 Td
(post-translational)Tj
7.2509 0 Td
(modification)Tj
5.3745 0 Td
(required)Tj
3.6397 0 Td
(for)Tj
1.3833 0 Td
(sustained)Tj
3.9684 0 Td
(MALT1)Tj
3.4243 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0749 0 Td
(Fur-)Tj
-34.6561 -1.2983 Td
(thermore,)Tj
4.1839 0 Td
(two)Tj
1.7121 0 Td
(isoforms)Tj
3.702 0 Td
(of)Tj
1.0148 0 Td
(MALT1)Tj
3.4242 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1203 0 Td
(reported.)Tj
3.8891 0 Td
(Isoform)Tj
3.4129 0 Td
(B)Tj
0.7993 0 Td
(is)Tj
0.8448 0 Td
(shorter)Tj
3.084 0 Td
(than)Tj
2.0296 0 Td
(A,)Tj
1.1282 0 Td
(missing)Tj
-33.4032 -1.2983 Td
(11)Tj
1.1678 0 Td
(residues)Tj
3.4866 0 Td
(encoded)Tj
3.6 0 Td
(by)Tj
1.1792 0 Td
(exon)Tj
2.1656 0 Td
(7.)Tj
0.9241 0 Td
(Alternative)Tj
4.6658 0 Td
(splicing)Tj
3.3165 0 Td
(of)Tj
1.0148 0 Td
(MALT1)Tj
3.4243 0 Td
(in)Tj
1.0318 0 Td
(T)Tj
0.8334 0 Td
(lymphocytes)Tj
5.2554 0 Td
(was)Tj
1.6951 0 Td
(recently)Tj
-33.7604 -1.3039 Td
(shown)Tj
2.8459 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(a)Tj
0.652 0 Td
(regulated)Tj
3.9401 0 Td
(process)Tj
3.1861 0 Td
(and)Tj
1.7292 0 Td
(a)Tj
0.6519 0 Td
(suppressor)Tj
4.5411 0 Td
(of)Tj
1.0148 0 Td
(exon)Tj
2.16 0 Td
(7)Tj
0.6973 0 Td
(inclusion)Tj
3.9174 0 Td
(was)Tj
1.7008 0 Td
(identified)Tj
4.0592 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
-33.2728 -1.2982 Td
(Remarkably,)Tj
5.2497 0 Td
(exon)Tj
2.1656 0 Td
(7)Tj
0.6974 0 Td
(encodes)Tj
3.4355 0 Td
(one)Tj
1.6951 0 Td
(key)Tj
1.5988 0 Td
(TRAF6-binding)Tj
6.6217 0 Td
(motif)Tj
2.398 0 Td
(\(T6BM\))Tj
3.4583 0 Td
(between)Tj
3.5319 0 Td
(the)Tj
1.4684 0 Td
(second)Tj
-32.3204 -1.2983 Td
(immunoglobulin-like)Tj
8.8043 0 Td
(domain)Tj
3.3279 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(paracaspase)Tj
4.9323 0 Td
(domain)Tj
3.3222 0 Td
(which)Tj
2.6532 0 Td
(is)Tj
0.8447 0 Td
(consequently)Tj
5.4935 0 Td
(missing)Tj
3.3052 0 Td
(in)Tj
-35.8807 -1.3039 Td
(MALT1B)Tj
4.0024 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1)Tj
0 g
(\).)Tj
-4.6261 -1.2983 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(report,)Tj
2.9366 0 Td
(we)Tj
1.3266 0 Td
(have)Tj
2.058 0 Td
(investigated)Tj
4.9889 0 Td
(further)Tj
3.0331 0 Td
(the)Tj
1.4683 0 Td
(changes)Tj
3.4016 0 Td
(occurring)Tj
4.1272 0 Td
(in)Tj
1.0318 0 Td
(MALT1)Tj
3.4242 0 Td
(following)Tj
3.9798 0 Td
(acti-)Tj
-35.7559 -1.2982 Td
(vation,)Tj
2.9536 0 Td
(by)Tj
1.1792 0 Td
(comparing)Tj
4.5751 0 Td
(the)Tj
1.4684 0 Td
(two)Tj
1.7121 0 Td
(isoforms)Tj
3.702 0 Td
(MALT1A)Tj
4.1045 0 Td
(and)Tj
1.7292 0 Td
(MALT1B)Tj
4.0025 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1)Tj
0 g
(\).)Tj
1.2642 0 Td
(We)Tj
1.6044 0 Td
(have)Tj
2.0636 0 Td
(identified)Tj
4.0592 0 Td
(a)Tj
-36.2378 -1.2983 Td
(novel)Tj
2.398 0 Td
(C-terminal)Tj
4.6432 0 Td
(auto-cleavage)Tj
5.6409 0 Td
(site)Tj
1.5704 0 Td
(at)Tj
0.9524 0 Td
(R781)Tj
2.2677 0 Td
(\(MALT1A\)/R770)Tj
7.1659 0 Td
(\(MALT1B\))Tj
4.6828 0 Td
(and)Tj
1.7292 0 Td
(demonstrate)Tj
5.2327 0 Td
(its)Tj
-36.2832 -1.3039 Td
(critical)Tj
2.948 0 Td
(impact)Tj
2.982 0 Td
(on)Tj
1.2756 0 Td
(MALT1)Tj
3.4185 0 Td
(B.)Tj
1.0262 0 Td
(This)Tj
1.9899 0 Td
(work)Tj
2.279 0 Td
(confirms)Tj
3.8041 0 Td
(that)Tj
1.7801 0 Td
(MALT1)Tj
3.4186 0 Td
(undergoes)Tj
4.3767 0 Td
(mono-ubiquitina-)Tj
-29.2987 -1.2983 Td
(tion)Tj
1.8425 0 Td
(after)Tj
2.0296 0 Td
(assembly)Tj
3.8267 0 Td
(into)Tj
1.8425 0 Td
(activating)Tj
4.1102 0 Td
(complexes.)Tj
4.6318 0 Td
(Although)Tj
4.0082 0 Td
(TRAF6)Tj
3.1407 0 Td
(does)Tj
2.0353 0 Td
(not)Tj
1.576 0 Td
(appear)Tj
2.914 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(respon-)Tj
-34.1345 -1.2983 Td
(sible)Tj
2.0239 0 Td
(for)Tj
1.3833 0 Td
(mono-ubiquitination)Tj
8.725 0 Td
(of)Tj
1.0148 0 Td
(MALT1,)Tj
3.651 0 Td
(interaction)Tj
4.6034 0 Td
(between)Tj
3.5319 0 Td
(TRAF6)Tj
3.1408 0 Td
(and)Tj
1.7291 0 Td
(MALT1)Tj
3.4186 0 Td
(has)Tj
1.5477 0 Td
(proved)Tj
-34.7695 -1.3039 Td
(essential)Tj
3.5829 0 Td
(for)Tj
1.3833 0 Td
(auto-proteolytic)Tj
6.6557 0 Td
(cleavage)Tj
3.5206 0 Td
(of)Tj
1.0148 0 Td
(MALT1)Tj
3.4243 0 Td
(at)Tj
0.9524 0 Td
(R149)Tj
2.2677 0 Td
(and)Tj
1.7291 0 Td
(overall)Tj
2.9027 0 Td
(MALT1)Tj
3.4242 0 Td
(protein)Tj
-30.8577 -1.2982 Td
(turnover.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 156.9826 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(Methods)Tj
/F0 1 Tf
-6.4961 -1.4976 Td
(Expression)Tj
5.1071 0 Td
(plasmids)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 122.0031 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(MALT1A)Tj
4.1045 0 Td
(and)Tj
1.7291 0 Td
(mutants)Tj
3.5093 0 Td
(thereof)Tj
3.0614 0 Td
(were)Tj
2.1203 0 Td
(cloned)Tj
2.897 0 Td
(into)Tj
1.8425 0 Td
(pCMVSport,)Tj
5.3801 0 Td
(encoding)Tj
3.9288 0 Td
(an)Tj
1.2075 0 Td
(N-terminal)Tj
4.7112 0 Td
(FLA-)Tj
-34.4917 -1.2982 Td
(G-His-Strep)Tj
5.1193 0 Td
(tag.)Tj
1.6384 0 Td
(BCL10)Tj
2.9537 0 Td
(and)Tj
1.7291 0 Td
(CARD11-L244P)Tj
6.7521 0 Td
(were)Tj
2.126 0 Td
(cloned)Tj
2.8913 0 Td
(into)Tj
1.8425 0 Td
(pcDNA6.2/V5-DEST)Tj
8.7363 0 Td
(\(Invitro-)Tj
-33.7887 -1.3039 Td
(gen\).)Tj
2.2223 0 Td
(The)Tj
1.7801 0 Td
(TRAF6-expressing)Tj
7.6932 0 Td
(plasmid)Tj
3.3959 0 Td
(was)Tj
1.7008 0 Td
(described)Tj
4.0478 0 Td
(previously)Tj
4.354 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(])Tj
1.8482 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(plasmid)Tj
-32.3657 -1.2983 Td
(encoding)Tj
3.9287 0 Td
(A20)Tj
1.8539 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
2.0806 0 Td
(The)Tj
1.7802 0 Td
(plasmids)Tj
3.753 0 Td
(for)Tj
1.389 0 Td
(expression)Tj
4.4617 0 Td
(of)Tj
1.0148 0 Td
(CYLD,)Tj
3.016 0 Td
(MALT1)Tj
3.4242 0 Td
(isoform)Tj
3.3392 0 Td
(B)Tj
0.7994 0 Td
(and)Tj
1.7291 0 Td
(TRAF2)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 433.644 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(TRAF6)Tj
3.3519 0 Td
(Controls)Tj
3.8765 0 Td
(MALT1)Tj
3.4016 0 Td
(Auto-Prote)Tj
4.7055 0 Td
(olysis)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0169)Tj
3.5434 0 Td
(026)Tj
2.6362 0 Td
(January)Tj
3.7134 0 Td
(4,)Tj
1.0417 0 Td
(2017)Tj
38.346 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
BT
66.402 0 Td
(28)Tj
ET
Q
endstream
endobj
64 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 68 0 R/Contents 69 0 R/TrimBox[0 0 612 792]>>
endobj
67 0 obj
<>stream
JFIF C
$, !$4.763.22:ASF:=N>22HbINVX]^]8EfmeZlS[]Y C**Y;2;YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY "
} !1AQa"q2#BR$3br
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz
w !1AQaq"2B #3Rbr
$4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? (
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(=(h2{iǿ[EψV/#e%!psO9:+;^K7C+x\L^e /[ 6_ +#ڔ/B ݸ !xrsV,QBI=^Q{+SH>{%|36^G8U nESG)E22ʸxRuiw"ghA#ԟZ 諸~XYaT؊ ! +Uc ~ ^Gk6VGf#t>j\iq1%DW`'Һ=6鶗eIJnPqƀ-QE!@Es:>]P'[ ( ( |c15$KجH8q 訬뗐У".;OoEPEPEPEPEPEƗ&2`3@PuEq^uֿ{um|1$EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPgAW Q\uv:? |? }wuC?w@EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEy